Warfarin Pharmacogenetics Dyfrig A. HughesMunir Pirmohamed Editorial 22 September 2012 Pages: 899 - 902
It’s Time to Choose the Study Design! Oren ShavitMoshe LeshnoAmnon Hoffman Leading Article 22 September 2012 Pages: 903 - 911
The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis Rachael L. FleurenceCynthia P. IglesiasJeanene M. Johnson Review Article 22 September 2012 Pages: 913 - 933
Economic Evaluations of Calcineurin Inhibitors in Renal Transplantation Alec H. MinersGuiqing YaoRod S. Taylor Review Article 22 September 2012 Pages: 935 - 947
Strategies for the Management of Suspected Heparin-Induced Thrombocytopenia Amanda R. PatrickWolfgang C. WinkelmayerMichael A. Fischer Original Research Article 22 September 2012 Pages: 949 - 961
Cost Effectiveness of Entecavir versus Lamivudine with Adefovir Salvage in HBeAg-Positive Chronic Hepatitis B David L. VeenstraSean D. SullivanRobert G. Gish Original Research Article 22 September 2012 Pages: 963 - 977
The Economic Impact of Introducing Serotonin-Noradrenaline Reuptake Inhibitors into the Brazilian National Drug Formulary M’arcio MachadoMichael IskedjianThomas R. Einarson Original Research Article 22 September 2012 Pages: 979 - 990